Dexmedetomidine for awake craniotomy without laryngeal mask

Arquivos de Neuro-Psiquiatria

Volumn 63, Issue 3 B, 2005, Pages 748-750

  Nogueira De Almeida, Antonio ^a,b   Tavares, Cristiane ^a   Tibano, Adriana ^a   Sasaki, Seigi ^a   Murata, Kazuco Nakai ^a   Marino Jr , Raul ^a  

^a Hospital Sao Joaquim   (Brazil)

^b NONE   (Brazil)

Author keywords

Awake craniotomy; Cortical mapping; Dexmedetomidine; Epilepsy surgery; Neuroanesthesia

Indexed keywords

DEXMEDETOMIDINE; DROPERIDOL; FENTANYL; MIDAZOLAM; PROPOFOL;

ADULT; AGITATION; ANESTHESIA; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CAVERNOUS HEMANGIOMA; CONSCIOUSNESS; CONVULSION; CRANIOTOMY; EPILEPSY; FEMALE; HEMODYNAMICS; HUMAN; LARYNGEAL MASK; MALE; NEUROSURGERY; RESPIRATION DEPRESSION; TREATMENT OUTCOME;

EID: 27144528816     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2005000500005     Document Type: Article

References (14)

1. Skirboll SS, Ojemann GA, Berger MS, Lettich, ER, Winn HR. Functional cortex and subcortical white matter located within gliomas. Neurosurgery 1996;38:678-685.
2. Danks RA, Rogers M, Aglio LS, Gugino LD, Black P. Patient tolerance of craniotomy performed with the patient under local anesthesia and monitored conscious sedation. Neurosurgery 1998;42:28-36.
3. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perception. Br J Anaesth 2001;87:684-690
4. Bekker AY, Kaufman B; Samir D; Doyle W. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001;92:1251-1253.
5. Ard J, Doyle W, Bekker A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesthesiol 2003;15:263-266.
6. Mizobe T, Maghsoudi K, Sitwala K, et al. Antisense technology reveals the alpha sub 2a adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat. J Clin Invest 1996;98:1076-1080.
7. Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997;85:1136-1142.
8. Hans P, Bonhomme V, Born JD, Maertens de Noordhoudt A, Brichant JF, Dewandre PY. Target-controlled infusion of propofol and remifentanil combined with bispectral index monitoring for awake craniotomy. Anesthesia 2000;55:255-259.
9. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-394.
10. Prielipp RC, Wall MH, Tobin JR, et al. dexmedetomidine-induced sedation in volunteers decrease regional e global cerebral blood flow. Anesth Analg 2002;95:1052-1059
11. Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg 2002;95:463-466.
12. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
13. Mirski MA, Rossell LA, McPherson RW, Traystman RJ. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology 1994;81:1422-1428.
14. Miyazaki Y, Adachi T, Kurata J, Utsumi J, Shichino T, Segawa H. Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats. Br J Anaesth 1999;82:935-937.